Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Assessing the Clinical Benefit of NMP22 in the Surveillance of Patients with Non-muscle-invasive Bladder Cancer and Negative Cytology: A Decision-curve Analysis